Apollomics, Inc. (APLM) Key Metrics
APLM valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $61.5M
- Enterprise value
- $65.6M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 7.0 10-yr median 45.6
- Price / book
- 8.1
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.54
APLM key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsAPLM valuation Price multiples at each fiscal year-end price.
Price / sales−93.0%
3.2
2025 · hover or tap a bar for each year
20192025
Free cash flow yield+280.1 pts
−38.4%
2025 · hover or tap a bar for each year
20192025
APLM returns How much profit the business earns on the capital it uses.
Return on assets+46.9 pts
−110.4%
2025 · hover or tap a bar for each year
20192025
Asset turnover+14,739.6%
0.86
2025 · hover or tap a bar for each year
20192025
APLM per-share figures Results divided by the shares outstanding at year-end.
Revenue per share+2,652.4%
$5.88
2025 · hover or tap a bar for each year
20192025
Earnings per share
−$7.57
2025 · hover or tap a bar for each year
20192025
Free cash flow per share
−$7.18
2025 · hover or tap a bar for each year
20192025
Book value per share
−$2.21
2025 · hover or tap a bar for each year
20192025
Dividends per share
$0.00
2025 · hover or tap a bar for each year
20192025
Shares outstanding+56.0%
1.4M
2025 · hover or tap a bar for each year
20192025
APLM financial health Debt, liquidity and how easily interest is covered.
Net debt+$6.2M
−$2.6M
2025 · hover or tap a bar for each year
20192025
Current ratio−31.1%
0.96
2025 · hover or tap a bar for each year
20192025
Interest coverage
-145.7
2025 · hover or tap a bar for each year
20192025
Debt / assets+29.9%
0.10
2025 · hover or tap a bar for each year
20192025
APLM efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−490 days
56 days
2025 · hover or tap a bar for each year
20192025
Capex / revenue−12.1 pts
0.0%
2025 · hover or tap a bar for each year
20192025
APLM valuation history
Fiscal year-endToday7-year median
APLM returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
APLM debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
APLM price vs earnings per share
Share price at year-endEPS (right axis)
APLM key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $27.0M | $9.0M | $71.8M | $899.2M | $861.9M | — | — |
| Enterprise value | $24.4M | $233,122 | $38.6M | $845.6M | $1.09B | — | — |
| Price / sales | 3.2 | 45.6 | 87.4 | — | — | — | — |
| Price / book | — | 1.9 | 1.7 | — | — | — | — |
| EV / sales | 2.9 | 1.2 | 47.1 | — | — | — | — |
| Earnings yield | −40.5% | −596.2% | −240.4% | −26.8% | −11.0% | — | — |
| Free cash flow yield | −38.4% | −318.5% | −60.2% | −4.8% | −5.9% | — | — |
| Dividend yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shareholder yield (dividends + buybacks) | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Share price at fiscal year-end | $18.70 | $9.75 | $96.50 | $1,036.00 | $993.00 | — | — |
| Per share | |||||||
| Revenue per share | $5.88 | $0.21 | $1.10 | $0.37 | $0.00 | $2.12 | $0.00 |
| Earnings per share | −$7.57 | −$58.13 | −$232.00 | −$277.45 | −$109.22 | −$86.20 | −$52.89 |
| Operating cash flow per share | −$7.18 | −$31.02 | −$58.08 | −$49.34 | −$49.90 | −$41.11 | −$25.28 |
| Free cash flow per share | −$7.18 | −$31.05 | −$58.09 | −$49.76 | −$58.60 | −$41.28 | −$26.27 |
| Cash per share | $2.27 | $10.54 | $50.83 | $62.92 | $108.86 | $177.87 | $85.40 |
| Book value per share | −$2.21 | $5.25 | $55.42 | −$516.29 | −$245.24 | −$147.40 | −$69.96 |
| Tangible book value per share | −$2.21 | $3.38 | $35.59 | −$533.32 | −$262.29 | −$159.28 | −$71.50 |
| Dividends per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Capex per share | $0.00 | $0.03 | $0.01 | $0.42 | $8.70 | $0.17 | $0.99 |
| Debt per share | $0.44 | $1.04 | $6.27 | $1.14 | $374.91 | $333.60 | $156.65 |
| Shares outstanding | 1.4M | 926K | 744K | 868K | 868K | 868K | 868K |
| Change in shares outstanding | +56.0% | +24.5% | −14.3% | 0.0% | 0.0% | 0.0% | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | — | −233.7% | — | — | — | — | — |
| Return on invested capital (ROIC) | — | — | — | — | −317.7% | −768.6% | — |
| Return on assets (ROA) | −110.4% | −157.3% | −261.8% | −240.9% | −64.6% | −60.1% | −58.1% |
| Return on tangible assets | −162.9% | −474.1% | −424.8% | −390.3% | −87.3% | −46.9% | −59.1% |
| Free cash flow margin | −122.0% | — | — | — | — | — | — |
| Financial health | |||||||
| Total debt | $643,000 | $966,000 | $4.7M | $991,000 | $325.4M | $289.6M | $136.0M |
| Cash & short-term investments | $3.3M | $9.8M | $37.8M | $54.6M | $94.5M | $154.4M | $74.1M |
| Net debt | −$2.6M | −$8.8M | −$33.2M | −$53.6M | $230.9M | $135.2M | $61.8M |
| Debt / equity | — | 0.20 | 0.11 | — | — | — | — |
| Debt / assets | 0.10 | 0.07 | 0.08 | 0.01 | 2.64 | 1.70 | 1.72 |
| Current ratio | 0.96 | 1.39 | 2.95 | 4.51 | 7.33 | 12.97 | 16.48 |
| Quick ratio | 0.96 | 1.39 | 2.98 | 4.51 | 7.16 | 12.89 | 16.48 |
| Interest coverage | -145.7 | -235.4 | -360.1 | -484.7 | -612.7 | -564.5 | -538.0 |
| Working capital | −$275,000 | $2.9M | $26.4M | $43.4M | $85.8M | $144.6M | $70.9M |
| Invested capital | −$5.8M | −$3.9M | $8.1M | −$501.7M | $18.1M | $7.2M | $1.1M |
| Tangible asset value | −$3.2M | $3.1M | $26.5M | −$462.9M | −$227.7M | −$138.3M | −$62.1M |
| Net current asset value | −$3.9M | $2.0M | $25.8M | −$468.8M | −$236.9M | −$141.2M | −$64.3M |
| Graham net-net per share | −$3.29 | $1.76 | $31.96 | −$541.01 | −$276.87 | −$164.41 | −$75.33 |
| Capital allocation | |||||||
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Capex / revenue | 0.0% | 12.1% | 0.7% | 113.6% | 377,500.0% | 7.8% | — |
| Capex / depreciation | 0.00 | 0.07 | 0.01 | 0.47 | 11.09 | 0.03 | 2.32 |
| Stock-based compensation / revenue | −11.5% | 5,518.2% | 1,545.1% | 1,109.0% | 406,100.0% | 245.4% | — |
| R&D / revenue | 65.1% | 12,407.1% | 4,164.8% | 10,977.4% | 1,778,400.0% | 1,710.6% | — |
| SG&A / revenue | 146.4% | 8,973.7% | 2,514.1% | 3,079.6% | 764,550.0% | 600.8% | — |
| Efficiency | |||||||
| Days sales outstanding | 56.2 | 546.6 | 225.2 | 595.0 | 84,041.2 | 77.1 | — |
| Days of inventory on hand | — | — | -245.1 | — | 858.9 | 569.4 | — |
| Receivables turnover | 6.50 | 0.67 | 1.62 | 0.61 | 0.00 | 4.74 | 0.00 |
| Inventory turnover | — | — | — | — | 0.42 | 0.64 | — |
| Asset turnover | 0.86 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |
| Average receivables | $1.3M | $296,500 | $506,500 | $526,500 | $460,500 | $388,000 | $361,000 |
| Average inventory | — | — | −$466,000 | — | $1.6M | $950,000 | — |
| Intangibles / total assets | 0.0% | 13.3% | 26.6% | 19.3% | 12.0% | 6.1% | 1.7% |
Computed from APLM's annual financial statements (latest annual report filed April 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
APLM valuation and financial ratios
It ended the year with $0.6 million of debt and $3.3 million in cash and short-term investments, a net cash position of $2.6 million. The share count rose 66.5% from 868K to 1.4M over 6 years.
See the APLM income statement, the APLM chart for price history, or the APLM stock overview for the latest quote and news.
APLM key metrics FAQ
How much debt does Apollomics have?
Apollomics had total debt of $0.6 million at the end of fiscal 2025 and more cash than debt.
Does Apollomics pay a dividend?
Apollomics did not pay a dividend in fiscal 2025.
What is Apollomics's free cash flow yield?
Apollomics generated -$10.4 million of free cash flow in fiscal 2025, a free cash flow yield of −38.4% on its market value at year-end ($27.0 million).
What is Apollomics's current ratio?
Apollomics's current ratio was 0.96 at the end of fiscal 2025: current assets were 0.96 times current liabilities.